Bbr Partners, LLC Abb Vie Inc. Transaction History

Bbr Partners, LLC

$1.3 Billion
Q3 2024

A detailed history of Bbr Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bbr Partners, LLC holds 61,465 shares of ABBV stock, worth $10.8 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

61,465

Previous 54,887 11.98%

Holding current value

$10.8 Million

Previous $9.41 Million 28.94%

% of portfolio

0.93%

Previous 0.77%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $1.08 Million - $1.31 Million	6,578 Added 11.98%	61,465 $12.1 Million
Q2 2024 Aug 05, 2024	SELL	$154.79 - $180.76 $1.26 Million - $1.48 Million	-8,162 Reduced 12.95%	54,887 $9.41 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $1.14 Million - $1.3 Million	7,144 Added 12.78%	63,049 $11.5 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $82,972 - $93,446	603 Added 1.09%	55,905 $8.66 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $453,404 - $524,882	3,394 Added 6.54%	55,302 $8.24 Million
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $27,694 - $34,464	-209 Reduced 0.4%	51,908 $6.99 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $12,291 - $14,155	-85 Reduced 0.16%	52,117 $8.31 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $7,468 - $8,956	54 Added 0.1%	52,202 $8.44 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $333,914 - $382,977	-2,488 Reduced 4.55%	52,148 $7 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $68,810 - $87,480	-500 Reduced 0.91%	54,636 $8.37 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $2.17 Million - $2.69 Million	16,445 Added 42.5%	55,136 $8.94 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $17,940 - $22,700	167 Added 0.43%	38,691 $5.24 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $312,816 - $355,093	-2,940 Reduced 7.09%	38,524 $4.16 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $36,087 - $40,203	-343 Reduced 0.82%	41,464 $4.67 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $2,659 - $2,928	26 Added 0.06%	41,807 $4.52 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $6,761 - $9,128	84 Added 0.2%	41,781 $4.48 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $280,667 - $329,411	3,267 Added 8.5%	41,697 $3.65 Million
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $212,112 - $283,838	-2,891 Reduced 7.0%	38,430 $3.77 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $20,317 - $30,803	315 Added 0.77%	41,321 $3.15 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $1,875 - $2,346	-26 Reduced 0.06%	41,006 $3.63 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $2,582 - $3,104	41 Added 0.1%	41,032 $3.11 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $62,237 - $69,188	700 Added 1.74%	40,991 $3.88 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $3.24 Million - $3.83 Million	36,070 Added 854.54%	40,291 $3.73 Million
Q1 2018 May 10, 2018	BUY	$92.01 - $123.21 $388,374 - $520,069	4,221 New	4,221 $400,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bbr Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bbr Partners, LLC with notifications on news.

Account